HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yao-Chi Chuang Selected Research

Infections

1/2020Therapeutic Efficacy of onabotulinumtoxinA Delivered Using Various Approaches in Sensory Bladder Disorder.
12/2011Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma.
10/2009Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yao-Chi Chuang Research Topics

Disease

18Overactive Urinary Bladder (Overactive Bladder)
03/2022 - 10/2008
14Pain (Aches)
04/2022 - 01/2003
12Interstitial Cystitis (Interstitial Cystitis, Chronic)
03/2022 - 01/2003
11Inflammation (Inflammations)
03/2022 - 04/2007
11Lower Urinary Tract Symptoms
01/2022 - 07/2006
9Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2019 - 10/2005
7Prostatitis
04/2022 - 12/2006
7Shock
03/2022 - 08/2016
7Cystitis
01/2022 - 09/2008
5Neoplasms (Cancer)
03/2022 - 07/2009
5Hypertension (High Blood Pressure)
01/2022 - 04/2012
5Underactive Urinary Bladder
04/2019 - 01/2014
4Nocturia
01/2022 - 07/2014
4Urinary Tract Infections (Urinary Tract Infection)
01/2021 - 06/2014
3Erectile Dysfunction
03/2022 - 08/2016
3Stress Urinary Incontinence
03/2022 - 09/2011
3Urge Urinary Incontinence (Urge Incontinence)
01/2021 - 08/2014
3Neoplasm Metastasis (Metastasis)
01/2021 - 07/2009
3Infections
01/2020 - 10/2009
3Prostatic Neoplasms (Prostate Cancer)
09/2016 - 07/2009
3Stroke (Strokes)
08/2016 - 07/2013
2Constipation
10/2022 - 01/2021
2Carcinoma (Carcinomatosis)
01/2021 - 12/2011
2Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
05/2020 - 04/2006
2Hemorrhage
11/2019 - 11/2018
2Ataxia (Dyssynergia)
10/2019 - 12/2006
2Hypersensitivity (Allergy)
09/2019 - 07/2009
2Urinary Retention
12/2014 - 11/2006
2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2013 - 04/2012
2Hemorrhagic Cystitis
06/2013 - 04/2013
2Atrophy
10/2009 - 04/2006
1Pelvic Pain
03/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Nervous System Diseases (Neurological Disorders)
01/2022
1Urinary Calculi (Urinary Calculus)
09/2021
1Urologic Neoplasms (Urological Cancer)
09/2021
1Dysuria
01/2021
1Fibrosis (Cirrhosis)
11/2019
1Hyperalgesia
09/2019
1Edema (Dropsy)
09/2019
1Heart Diseases (Heart Disease)
11/2018

Drug/Important Bio-Agent (IBA)

17Type A Botulinum Toxins (Botox)FDA Link
12/2021 - 10/2004
8Liposomes (Liposome)IBA
01/2020 - 10/2009
7Pharmaceutical PreparationsIBA
03/2022 - 03/2006
7incobotulinumtoxinAFDA Link
10/2019 - 11/2006
5Capsaicin (Zostrix)FDA Link
04/2022 - 04/2005
5Botulinum Toxins (Botulinum Toxin)IBA
08/2016 - 12/2006
3Solifenacin SuccinateFDA Link
10/2022 - 10/2008
34-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2022 - 11/2017
3Therapeutic UsesIBA
09/2019 - 09/2013
3Analgesics (Analgesic Drugs)IBA
08/2017 - 01/2003
3Testosterone (Sustanon)FDA Link
08/2016 - 07/2012
3C-Reactive ProteinIBA
07/2014 - 04/2012
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2011 - 07/2009
3ProstaglandinsIBA
12/2010 - 08/2008
2Cisplatin (Platino)FDA LinkGeneric
03/2022 - 09/2021
2KetamineFDA LinkGeneric
11/2019 - 11/2018
2Substance PIBA
11/2019 - 11/2018
2Nerve Growth Factor (NGF)IBA
08/2017 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 01/2014
2Prostate-Specific Antigen (Semenogelase)IBA
09/2016 - 07/2009
2AndrogensIBA
08/2016 - 07/2013
2Acetic Acid (Vinegar)FDA LinkGeneric
08/2016 - 10/2004
2CreatinineIBA
08/2016 - 07/2014
2Hemoglobins (Hemoglobin)IBA
07/2014 - 04/2012
2Serum AlbuminIBA
07/2014 - 07/2012
2Dinoprostone (PGE2)FDA Link
01/2014 - 03/2011
2Tacrolimus (Prograf)FDA LinkGeneric
04/2013 - 03/2011
2Protective AgentsIBA
10/2011 - 10/2009
2Prostaglandins EIBA
12/2010 - 07/2009
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2009 - 08/2008
2Opioid Peptides (Opioid Peptide)IBA
04/2005 - 11/2003
2Complementary DNA (cDNA)IBA
04/2005 - 11/2003
1Cytochromes c (Cytochrome c)IBA
01/2022
1Caspase 3 (Caspase-3)IBA
01/2022
1imidafenacinIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1indolepropanol phosphate (IPP)IBA
05/2020
1Protamines (Protamine Sulfate)FDA Link
01/2020
1phosphatidylethanolamineIBA
01/2020
1mirabegronIBA
01/2020
1HydrogelsIBA
01/2020
1Hyaluronic Acid (Hyaluronan)IBA
01/2020
1Uroplakin IIIIBA
11/2019
1hachimijiogan (TJ 7)IBA
11/2019
1die-huang-wanIBA
11/2019
1Proteins (Proteins, Gene)FDA Link
11/2018
1Cadherins (E-Cadherin)IBA
11/2018
1Interleukin-6 (Interleukin 6)IBA
08/2017

Therapy/Procedure

13Therapeutics
03/2022 - 09/2008
9Extracorporeal Shockwave Therapy
04/2022 - 01/2017
4Intravesical Administration
01/2017 - 10/2009
3Drug Therapy (Chemotherapy)
09/2021 - 06/2013
2Nephroureterectomy
01/2021 - 12/2011
2Injections
01/2017 - 09/2008
2Blood Transfusion (Blood Transfusions)
07/2011 - 03/2010
2Analgesia
04/2005 - 10/2004
1Lithotripsy (Extracorporeal Shockwave Lithotripsy)
09/2021
1Oral Administration
01/2021
1Anesthesia
01/2020